Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

1.

High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study.

Besser M, Baglin C, Luddington R, van Hylckama Vlieg A, Baglin T.

J Thromb Haemost. 2008 Oct;6(10):1720-5. doi: 10.1111/j.1538-7836.2008.03117.x. Epub 2008 Aug 1.

PMID:
18680535
[PubMed - indexed for MEDLINE]
2.

The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosis.

Buyue Y, Whinna HC, Sheehan JP.

Blood. 2008 Oct 15;112(8):3234-41. doi: 10.1182/blood-2008-01-136820. Epub 2008 Jul 22.

PMID:
18647957
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism.

Tripodi A, Legnani C, Chantarangkul V, Cosmi B, Palareti G, Mannucci PM.

J Thromb Haemost. 2008 Aug;6(8):1327-33. doi: 10.1111/j.1538-7836.2008.03018.x. Epub 2008 May 15.

PMID:
18485081
[PubMed - indexed for MEDLINE]
4.

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.

Amadeus Investigators, Bousser MG, Bouthier J, Büller HR, Cohen AT, Crijns H, Davidson BL, Halperin J, Hankey G, Levy S, Pengo V, Prandoni P, Prins MH, Tomkowski W, Torp-Pedersen C, Wyse DG.

Lancet. 2008 Jan 26;371(9609):315-21. doi: 10.1016/S0140-6736(08)60168-3. Erratum in: Lancet. 2008 Dec 13;372(9655):2022.. Thorp-Pedersen, C [corrected to Torp-Pedersen, C].

PMID:
18294998
[PubMed - indexed for MEDLINE]
5.

Extended prophylaxis of venous thromboembolism with idraparinux.

van Gogh Investigators, Buller HR, Cohen AT, Davidson B, Decousus H, Gallus AS, Gent M, Pillion G, Piovella F, Prins MH, Raskob GE.

N Engl J Med. 2007 Sep 13;357(11):1105-12.

PMID:
17855671
[PubMed - indexed for MEDLINE]
Free Article
6.

The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic tenase complex: the role of arginine 165 and factor X.

Misenheimer TM, Buyue Y, Sheehan JP.

Biochemistry. 2007 Jul 3;46(26):7886-95. Epub 2007 Jun 12.

PMID:
17563121
[PubMed - indexed for MEDLINE]
7.

Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation.

Hron G, Kollars M, Binder BR, Eichinger S, Kyrle PA.

JAMA. 2006 Jul 26;296(4):397-402.

PMID:
16868297
[PubMed - indexed for MEDLINE]
8.

Depolymerized holothurian glycosaminoglycan and heparin inhibit the intrinsic tenase complex by a common antithrombin-independent mechanism.

Sheehan JP, Walke EN.

Blood. 2006 May 15;107(10):3876-82. Epub 2006 Jan 10.

PMID:
16672689
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Thrombin generation profiles in deep venous thrombosis.

Brummel-Ziedins KE, Vossen CY, Butenas S, Mann KG, Rosendaal FR.

J Thromb Haemost. 2005 Nov;3(11):2497-505.

PMID:
16241948
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycans.

Pike RN, Buckle AM, le Bonniec BF, Church FC.

FEBS J. 2005 Oct;272(19):4842-51. Review.

PMID:
16176258
[PubMed - indexed for MEDLINE]
Free Article
12.

The plasma hemostatic proteome: thrombin generation in healthy individuals.

Brummel-Ziedins K, Vossen CY, Rosendaal FR, Umezaki K, Mann KG.

J Thromb Haemost. 2005 Jul;3(7):1472-81.

PMID:
15978105
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.

Yuan QP, Walke EN, Sheehan JP.

Biochemistry. 2005 Mar 8;44(9):3615-25.

PMID:
15736971
[PubMed - indexed for MEDLINE]
14.

Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition.

Luddington R, Baglin T.

J Thromb Haemost. 2004 Nov;2(11):1954-9.

PMID:
15550027
[PubMed - indexed for MEDLINE]
15.

Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation.

Kitazato K, Kitazato KT, Sasaki E, Minamiguchi K, Nagase H.

Thromb Res. 2003;112(1-2):83-91.

PMID:
15013278
[PubMed - indexed for MEDLINE]
16.

Thrombin generation: phenotypic quantitation.

Brummel-Ziedins KE, Pouliot RL, Mann KG.

J Thromb Haemost. 2004 Feb;2(2):281-8.

PMID:
14995991
[PubMed - indexed for MEDLINE]
17.

Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.

Sheehan JP, Kobbervig CE, Kirkpatrick HM.

Biochemistry. 2003 Sep 30;42(38):11316-25.

PMID:
14503882
[PubMed - indexed for MEDLINE]
18.

Calibrated automated thrombin generation measurement in clotting plasma.

Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Béguin S.

Pathophysiol Haemost Thromb. 2003;33(1):4-15.

PMID:
12853707
[PubMed - indexed for MEDLINE]
19.

Depolymerized holothurian glycosaminoglycan (DHG), a novel alternative anticoagulant for hemodialysis, is safe and effective in a dog renal failure model.

Minamiguchi K, Kitazato KT, Nagase H, Sasaki E, Ohwada K, Kitazato K.

Kidney Int. 2003 Apr;63(4):1548-55.

PMID:
12631372
[PubMed - indexed for MEDLINE]
20.

A model for the stoichiometric regulation of blood coagulation.

Hockin MF, Jones KC, Everse SJ, Mann KG.

J Biol Chem. 2002 May 24;277(21):18322-33. Epub 2002 Mar 13.

PMID:
11893748
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk